Čájehuvvojit 1 - 10 oktiibuot 10 bohtosis ohcui "BRCA family"', ohcanáigi: 0,01s Aiddostahte ozu
  1. 1
    Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification Dahkki Robert L. Hollis (15034814)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification Dahkki Robert L. Hollis (15034814)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors Dahkki Katrina M. Lappin (9340394)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification Dahkki Robert L. Hollis (15034814)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification Dahkki Robert L. Hollis (15034814)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification Dahkki Robert L. Hollis (15034814)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification Dahkki Robert L. Hollis (15034814)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors Dahkki Katrina M. Lappin (9340394)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors Dahkki Katrina M. Lappin (9340394)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors Dahkki Katrina M. Lappin (9340394)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: